Dr. Fjording will be based at BioAgilytix’s European laboratory in Hamburg, Germany and will provide scientific and regulatory oversight to BioAgilytix’s team in the development and implementation of strategies for bioanalytical assay development and regulated assay validation.
The end-to-end service handles all aspects of sample collection logistics, testing, and results reporting for employers, providing an easy-to-implement solution to effectively mitigate COVID-19 exposure within their workforces.
The new name is reflective of BioAgilytix’s plan, which was set forth following its acquisition of Boston-based Cambridge Biomedical in late 2019, to fully integrate Cambridge Biomedical’s clinical and diagnostic testing capabilities into BioAgilytix’s global service offerings.
BioAgilytix supplies its assay expertise to describe the appropriate analytical assays needed to determine and ensure that biosimilar critical quality parameters are on track.
In this role, Dr. Briscoe will provide scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.
In this role, Dr. Nicholson will oversee bioanalytical operations and scientific team development across BioAgilytix’s laboratories in both the USA and Europe, with particular focus leading the organization’s Gene and Cell Therapy bioanalytical services.
In this article, Bioanalysis Zone explores the launch of BioAgilytix’s new range of customizable COVID-19 testing packages with commentary from leadership team members.
This article by Applied Clinical Trials explores BioAgilytix’s new customizable COVID-19 testing packages that include services to address sponsor needs stemming from the coronavirus pandemic.
WRAL TechWire lists BioAgilytix’s new COVID-19 testing packages as noteworthy technology news affecting the North Carolina ecosystem.
This article by Verdict Medical Devices explores BioAgilytix’s new customizable COVID-19 testing packages, which include return-to-work screening for employers and assays for clinical sponsors.
Services
Platforms